← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$24K

Shares

796

Price

$31

Filed

Dec 16

Insider

Name

Bredt David

Title

Chief Scientific Officer

CIK

0002022087

Roles

Officer

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

392,642

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2024. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.58 to $30.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.61 to $30.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Filing Info

Accession No.

0001193125-25-321142

Form Type

4

Issuer CIK

0002012593

Bredt David's History

Date Ticker Type Value
2025-12-31 RAPP A
2025-12-31 RAPP $197K
2025-12-15 RAPP $231K
2025-12-15 RAPP $24K
2025-11-17 RAPP $78K
2025-11-17 RAPP $136K
2025-10-15 RAPP $191K
2025-10-15 RAPP $28K
2025-09-15 RAPP $122K
2025-09-15 RAPP $84K

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Gault Cheryl
Chief Operating Officer
$282K 2026-03-30
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17